Clinical Trials Directory

Trials / Terminated

TerminatedNCT00277056

Dysregulated Tyrosine Kinase Signaling in Leukemia

Status
Terminated
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dysregulated Tyrosine Kinase Signaling in Leukemia

Detailed description

Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying

Conditions

Timeline

Start date
2002-05-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2006-01-13
Last updated
2024-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00277056. Inclusion in this directory is not an endorsement.